Large meals and large arteries: Is resistin the link?

Cardiovascular Research

Volumn 69, Issue 1, 2006, Pages 9-12

  Herrmann, Joerg ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; RESISTIN; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL AORTA ANEURYSM; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CELL MIGRATION; CYTOKINE PRODUCTION; DOWN REGULATION; EDITORIAL; ENDOTHELIUM CELL; HUMAN; MACROPHAGE ACTIVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOGENESIS;

ATHEROSCLEROSIS; GENE EXPRESSION; HUMANS; METABOLIC SYNDROME X; MYOCARDITIS; NF-KAPPA B; OBESITY; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 29144461620     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.10.005     Document Type: Editorial

References (30)

1. R. Horton The neglected epidemic of chronic disease Lancet 366 2005 1514
2. G.M. Reaven Banting lecture 1988. Role of insulin resistance in human disease. 1988 Nutrition 13 1997 65
3. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2005 2735 2752
4. K.G. Alberti, P. Zimmet, and J. Shaw IDF epidemiology task force consensus group. The metabolic syndrome-a new worldwide definition Lancet 366 2005 1059 1062
5. C.M. Steppan, and M.A. Lazar The current biology of resistin J Intern Med 255 2004 439 447
6. C.M. Kusminski, P.G. McTernan, and S. Kumar Role of resistin in obesity, insulin resistance and Type II diabetes Clin Sci 109 2005 243 256
7. J.J. Diez, P. Iglesias, M.J. Fernandez-Reyes, A. Aguilera, M.A. Bajo, and P. Alvarez-Fidalgo Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease Clin Endocrinol 62 2005 242 249
8. M.P. Reilly, M. Lehrke, M.L. Wolfe, A. Rohatgi, M.A. Lazar, and D.J. Rader Resistin is an inflammatory marker of atherosclerosis in humans Circulation 111 2005 932 939
9. R. Ohmori, Y. Momiyama, R. Kato, H. Taniguchi, M. Ogura, and M. Ayaori Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease J Am Coll Cardiol 46 2005 379 380
10. N. Al-Daghri, R. Chetty, P.G. McTernan, K. Al-Rubean, O. Al-Attas, and A.F. Jones Serum resistin is associated with c-reactive protein and ldl cholesterol in type 2 diabetes and coronary artery disease in a Saudi population Cardiovasc Diabetol 4 2005 10
11. H.S. Jung, K.H. Park, Y.M. Cho, S.S. Chung, H.J. Cho, and S.Y. Cho Resistin is secreted from macrophages in atheromas and promotes atherosclerosis Cardiovasc Res 69 2006 76 85 10.1016/j.cardiores.2005.09.015
12. S. Verma, S.H. Li, C.H. Wang, P.W. Fedak, R.K. Li, and R.D. Weisel Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction Circulation 108 2003 736 740
13. D. Kawanami, K. Maemura, N. Takeda, T. Harada, T. Nojiri, and Y. Imai Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions Biochem Biophys Res Commun 314 2004 415 419
14. P. Kougias, H. Chai, P.H. Lin, Q. Yao, A.B. Lumsden, and C. Chen Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease J Surg Res 126 2005 121 129
15. P. Calabro, I. Samudio, J.T. Willerson, and E.T. Yeh Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways Circulation 110 2004 3335 3340
16. N. Silswal, A.K. Singh, B. Aruna, S. Mukhopadhyay, S. Ghosh, and N.Z. Ehtesham Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway Biochem Biophys Res Commun 334 2005 1092 1101
17. M. Lehrke, M.P. Reilly, S.C. Millington, N. Iqbal, D.J. Rader, and M.A. Lazar An inflammatory cascade leading to hyperresistinemia in humans PLoS Med 1 2004 e45
18. M. Bokarewa, I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski Resistin, an adipokine with potent proinflammatory properties J Immunol 174 2005 5789 5795
19. D.B. Savage, C.P. Sewter, E.S. Klenk, D.G. Segal, A. Vidal-Puig, and R.V. Considine Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans Diabetes 50 2001 2199 2202
20. H. Ghanim, A. Aljada, D. Hofmeyer, T. Syed, P. Mohanty, and P. Dandona Circulating mononuclear cells in the obese are in a proinflammatory state Circulation 110 2004 1564 1571
21. G.S. Herron Vascular aneurysms: a side-splitting affair Cardiovasc Res 31 1996 224 230
22. M.D. Tilson III The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease Circulation 112 2005 154 156
23. M.J. Davies Aortic aneurysm formation: lessons from human studies and experimental models Circulation 98 1998 193 195
24. K. Saraff, F. Babamusta, L.A. Cassis, and A. Daugherty Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 23 2003 1621 1626
25. D. Shteinberg, M. Halak, S. Shapiro, A. Kinarty, E. Sobol, and N. Lahat Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response Eur J Vasc Endovasc Surg 20 2000 462 465
26. O.D. Defawe, A. Colige, C.A. Lambert, C. Munaut, P. Delvenne, and C.M. Lapiere TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas Cardiovasc Res 60 2003 205 213
27. M.S. Burnett, C.W. Lee, T.D. Kinnaird, E. Stabile, S. Durrani, and M.K. Dullum The potential role of resistin in atherogenesis Atherosclerosis 182 2005 241 248
28. L. Patel, A.C. Buckels, I.J. Kinghorn, P.R. Murdock, J.D. Holbrook, and C. Plumpton Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem Biophys Res Commun 300 2003 472 476
29. J.A. Domandy, B. Charbonnel, D.J.A. Eckland, E. Erdmann, M. Massi-Benedetti, and I.K. Moules Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289
30. M. von Eynatten, J.G. Schneider, S. Hadziselimovic, A. Hamann, A. Bierhaus, and P.P. Nawroth Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes Diabetes Care 28 2005 754 755